Figure 3.

The ABCDES3 of routine diabetes visits

ACEI—angiotensin-converting enzyme inhibitor, ARB—angiotensin receptor blocker, ASA—acetylsalicylic acid, GLP1RA—glucagon like peptide 1 receptor agonist, SGLT2I—sodium glucose transporter 2 inhibitor.

Adapted from the Diabetes Canada Clinical Practice Guidelines Expert Committee.⁸